# CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cur5g-a-novel-autophagy-inhibitor-exhibits-potent-synergistic-anticancer-effects/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jingxuan Chen,Yunpeng Shen,Bowen Wu,Peichang Yang,Gang‐Chun Sun,Xiaoting Liu,Pengfei Qiang,Yamei Gao,Fangfang Sha,Zirui Li,Lu Zhang |
| Citations | 17 |
| DOI | 10.1038/s41420-022-01217-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41420-022-01217-9.pdf |
| OpenAlex ID | https://openalex.org/W4307895418 |
| PMID | 36316321 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Lu Zhang](https://scholariq.org/researchers/lu-zhang/)

## Paper primary topic

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)

## Paper topics

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)
- [Endoplasmic Reticulum Stress and Disease](https://scholariq.org/topics/endoplasmic-reticulum-stress-and-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.